Overcoming Uncertainty and Listing the CVRs on the TSX

CVRs issued in Canadian transactions have frequently been structured as non-transferable contractual rights. This structure has limited holders’ ability to monetize their rights before milestones are achieved and has made independent valuation more difficult. Even in cases in which CVRs were made transferable, exchange listing has remained elusive owing to structural and regulatory considerations.

A key challenge for exchanges and regulators has been uncertainty regarding the satisfaction of milestones. Where milestones depend on subjective judgments or third-party actions with probabilistic outcomes, it can be difficult to establish a transparent, continuously tradable market price. This has been particularly evident in the pharmaceutical and biotechnology sectors, where CVR milestones often hinge on events like successful completion of clinical trials or receipt of regulatory approvals from bodies such as the U.S. Food and Drug Administration or Health Canada. These outcomes are inherently binary, their timing is uncertain and they are heavily influenced by factors outside the issuer's direct control which complicates ongoing price discovery and raises investor-protection considerations for public listing.

The Agnico Eagle CVRs stand in contrast. The milestones, while uncertain, are nonetheless tied to objective, publicly verifiable and standardized metrics: (i) public announcements of gold ounces in mineral reserves on the property and (ii) achievement of commercial production. These are objective facts with established reporting frameworks, not probabilistic third-party approvals. Combined with Agnico Eagle’s undertakings for quarterly material developments reporting and annual reserve disclosures, this structure provided the transparency, measurability and ongoing information flow necessary for the TSX to approve listing on a discretionary basis under the Sandbox program.

This listing demonstrates that, with the right design, CVRs can transition from opaque contractual rights to liquid, market-priced instruments – at least in sectors such as mining, where milestones lend themselves to objective assessment.

First-Ever Listing of Contingent Value Rights on the TSX